Skip to main navigation Skip to search Skip to main content

FOxTROT 4: Fluoropyrimidine, Oxaliplatin and Targeted-Receptor pre-Operative Therapy for patients with high risk, operable colon cancer

Project Details

Short titleFOxTROT 4: Fluoropyrimidine, Oxaliplatin and Targeted-Receptor pre-Operative Therapy for patients with high risk, operable colon cancer
StatusActive
Effective start/end date1/10/23 → 30/09/27

Funding

  • University of Leeds